We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go: TBC investment: £127,001
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go: Extended investment: Withheld
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go: Extended investment: £295,000
Stroli – the shopping trolley reimagined for modern needs. The shopping trolley, often associated with a particular image, is an untapped category ready for innovation. The market is flooded with generic, budget-friendly options that lack charm, with the exception of Rolser, which is pricier and claims the green niche. Stroli steps in as the go-to brand, offering a unique approach, positioning, voice, and eco-friendly credentials. Say goodbye to sore hands and plastic bags – Stroli makes shopping a pleasure with its high-quality, stylish trolley bags designed to enhance your convenience and style
days to go: Extended investment: Withheld
With support from the founders of Bulldog Skincare, Zoopla and Love Film, VITL's aim is to improve the nation's health by offering vitamin packs that are fully personalised to the customer. VITL uses artificial intelligence to decipher which nutrients a person needs to ensure a healthy lifestyle. Effectively cutting out the cost of a private nutritionist.

Pitch Rated

44%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £908,950
Troubadour, a brand that specializes in creating comfortable, functional, and sustainable bags for both work and weekends. They are committed to their impact on the planet and their communities, being a certified B Corp. In 2022, Troubadour acquired the Mujjo brand, a tech accessories company, which has aided in expanding their product range and accelerating product development and customer discovery. They have experienced significant revenue growth, with a 128% increase in 2022, and continue to see substantial growth in 2023, having sold to over 30,000 customers worldwide and gaining recognition for their sustainable bags and accessories.
days to go: Expired investment: £1,771,286
Bird and Blend Tea (BABT) is a British independent tea mixologist. The company claims to offer 100+ blends of tea in a vegan-friendly product range, employs 125+ people and runs a global e-commerce platform attracting 100,000 monthly users. It claims to have achieved a £3.97 million turnover in 2020-2021 despite lockdown closures of its retail stores. BABT asserts that it operates 13 experiential retail stores across the UK since its last crowdfund in 2017. It has also featured in press entities such as The Independent, OK!, Huff Post, The Telegraph, and GQ Magazine. The company states it will use the investment to expedite the growth of its brand with investments in digital innovation, develop its technology stack, strengthen its team, open more multisensory stores, and undertake impactful projects to achieve B Corp status.
days to go: Expired investment: £999,867
WeTRAIN is a new way to have fun with personal training. They are the first shared personal training company and by doing this, they are creating a market of social exercise. WeTRAIN makes it easy for friends to have high quality, personalised training in a variety of different classes.
days to go: Expired investment: £437,138
JOHNNY'S is an ethical, vegan, and sex-positive subscription condom brand. The company aims to deliver its products on a subscription basis, following in the footsteps of Direct-To-Consumer (DTC) health disruptors like Harry's and Dollar Shave Club. It aims to become a contender in the global condom market that is set to be worth $15 Billion by 2026 and enter the lubricant and sex toy market later in 2021. The company has also pledged to give a condom to HIV/STI/NHS clinics for each condom sold. It will use the investment for a PR launch, social media advertising, stock purchase, and attract talent to help the business hit its growth targets.
days to go: Expired investment: £182,281
TOG designs handmade kitchen knives that are forged in the Samurai sword. By working with craftsmen in Seki, Japan, this company has produced knives and a brand that met its customers' needs. It has been endorsed by ten Michelin star chefs and appeared on cooking shows such as Masterchef. In 2017 and 2018, TOG Knives reached 18k profit (EBITDA £19.5k). Currently, it is aiming to be the UK's No.1 premium knife brand by helping people realise how enjoyable food preparation is, only if, one owns the right knife. With the fund raised, it will purchase stock, grow its team, shift its staff to full time and hiring new people.
days to go: Expired investment: £193,810
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph